目的：观察及比较瘢痕子宫中期妊娠引产利凡诺羊膜腔注射与口服米非司酮米索前列醇的临床效果。方法：选取2012年1月至2014年10月于本院进行中期妊娠引产的92例瘢痕子宫患者为研究对象，将其随机分为 A 组（利凡诺羊膜腔注射组）46例和 B 组（口服米非司酮和米索前列醇组）46例，然后将两组患者用药前后的血清及宫颈黏液相关指标、用药后不同时间的 Bishop 评分、VAS 评分及流产情况进行分别统计及比较。结果：B 组用药后不同时间的血清及宫颈黏液相关指标水平均高于 A 组，用药后不同时间的 Bishop 评分、VAS 评分及流产情况也均好于 A 组，P 均＜0．05，均有显著性差异。结论：口服米非司酮与米索前列醇在瘢痕子宫中期妊娠引产中的临床效果较好，对于改善宫颈软化情况及降低疼痛感均发挥着积极的临床作用。%Objectives:To observe and compare the clinical effect of rivanol by amniotic cavity injection and oral mifepristone and misoprostol in scar uterus induction of labor in midpregnancy.Methods:92 patients with scar uterus induction of labor in midpregnancy in our hospital from January 2012 to October 2014 were selected and randomly divided into group A (rivanol by amniotic cavity injection,46 cases)and group B (mifepristone and miso-prostol taken orally,46 cases).The serum and cervical mucus related indexes before and after the treatment,Bish-op score,VAS score and labor situation at different time after the treatment of two groups were respectively recorded and compared.Results:The serum and cervical mucus related indexes of group B at different time after the treat-ment were higher than those of group A,and the Bishop score,VAS score and labor situation at different time after the treatment were all better than those of group A,all P <0.05 with significant differences.Conclusions:The clinical effect of oral mifepristone and misoprostol in scar uterus induction of labor in midpregnancy is much better, which also plays an active role in improving cervical softening and relaxing pain.
展开▼
